Comprehensive Stock Comparison
Compare Kenvue Inc. (KVUE) vs The Procter & Gamble Company (PG) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | PG | 0.3% revenue growth vs KVUE's 0.1% |
| Value | KVUE | Lower P/E (17.0x vs 24.0x) |
| Quality / Margins | PG | 19.3% net margin vs KVUE's 9.5% |
| Stability / Safety | PG | Beta 0.12 vs KVUE's 0.22, lower leverage |
| Dividends | KVUE | 4.2% yield, vs PG's 2.4% |
| Momentum (1Y) | PG | -1.4% vs KVUE's -15.5% |
| Efficiency (ROA) | PG | 12.9% ROA vs KVUE's 5.3%, ROIC 20.1% vs 7.8% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Kenvue is a consumer health company that sells over-the-counter medications, skincare products, and essential health items through well-known brands like Tylenol, Neutrogena, and Band-Aid. It generates revenue primarily from three segments: Self Care (pain relief, allergy, digestive health), Skin Health and Beauty (skincare, haircare), and Essential Health (oral care, baby care, wound care) — each contributing roughly one-third of sales. The company's key advantage is its portfolio of trusted, household-name brands with decades of consumer loyalty and recognition.
Procter & Gamble is a global consumer goods giant that sells everyday household products across beauty, grooming, health, fabric care, and baby care categories. It generates revenue primarily through product sales across its five main segments — Fabric & Home Care (~35% of sales), Baby & Family Care (~25%), Health Care (~15%), Beauty (~15%), and Grooming (~10%). Its competitive moat lies in its massive portfolio of iconic, trusted brands — like Tide, Pampers, and Gillette — that enjoy deep consumer loyalty and dominate retail shelf space worldwide.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
PG leads in 4 of 6 categories (Financial Metrics, Profitability & Efficiency). KVUE leads in 1 (Valuation Metrics). 1 tied.
Financial Metrics (TTM)
PG is the larger business by revenue, generating $85.3B annually — 5.7x KVUE's $15.0B. PG is the more profitable business, keeping 19.3% of every revenue dollar as net income compared to KVUE's 9.5%. On growth, PG holds the edge at +1.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | KVUEKenvue Inc. | PGThe Procter & Gam… |
|---|---|---|
| RevenueTrailing 12 months | $15.0B | $85.3B |
| EBITDAEarnings before interest/tax | $2.9B | $22.5B |
| Net IncomeAfter-tax profit | $1.4B | $16.5B |
| Free Cash FlowCash after capex | $1.6B | $14.8B |
| Gross MarginGross profit ÷ Revenue | +58.1% | +50.7% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +23.6% |
| Net MarginNet income ÷ Revenue | +9.5% | +19.3% |
| FCF MarginFCF ÷ Revenue | +10.9% | +17.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.5% | +1.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +5.0% | -5.3% |
Valuation Metrics
At 25.7x trailing earnings, PG trades at a 27% valuation discount to KVUE's 35.4x P/E. On an enterprise value basis, PG's 17.8x EV/EBITDA is more attractive than KVUE's 18.0x.
| Metric | KVUEKenvue Inc. | PGThe Procter & Gam… |
|---|---|---|
| Market CapShares × price | $36.6B | $388.5B |
| Enterprise ValueMkt cap + debt − cash | $44.3B | $414.4B |
| Trailing P/EPrice ÷ TTM EPS | 35.41x | 25.68x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.05x | 24.01x |
| PEG RatioP/E ÷ EPS growth rate | — | 4.59x |
| EV / EBITDAEnterprise value multiple | 17.98x | 17.79x |
| Price / SalesMarket cap ÷ Revenue | 2.37x | 4.61x |
| Price / BookPrice ÷ Book value/share | 3.80x | 7.85x |
| Price / FCFMarket cap ÷ FCF | 27.44x | 27.66x |
Profitability & Efficiency
PG delivers a 30.9% return on equity — every $100 of shareholder capital generates $31 in annual profit, vs $13 for KVUE. PG carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to KVUE's 0.90x.
| Metric | KVUEKenvue Inc. | PGThe Procter & Gam… |
|---|---|---|
| ROE (TTM)Return on equity | +13.5% | +30.9% |
| ROA (TTM)Return on assets | +5.3% | +12.9% |
| ROICReturn on invested capital | +7.8% | +20.1% |
| ROCEReturn on capital employed | +8.7% | +23.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.90x | 0.68x |
| Net DebtTotal debt minus cash | $7.6B | $25.9B |
| Cash & Equiv.Liquid assets | $1.1B | $9.6B |
| Total DebtShort + long-term debt | $8.7B | $35.5B |
| Interest CoverageEBIT ÷ Interest expense | 5.22x | 52.82x |
Total Returns (with DRIP)
A $10,000 investment in PG five years ago would be worth $14,991 today (with dividends reinvested), compared to $7,941 for KVUE. Over the past 12 months, PG leads with a -1.4% total return vs KVUE's -15.5%. The 3-year compound annual growth rate (CAGR) favors PG at 9.2% vs KVUE's -7.4% — a key indicator of consistent wealth creation.
| Metric | KVUEKenvue Inc. | PGThe Procter & Gam… |
|---|---|---|
| YTD ReturnYear-to-date | +11.6% | +18.6% |
| 1-Year ReturnPast 12 months | -15.5% | -1.4% |
| 3-Year ReturnCumulative with dividends | -20.6% | +30.3% |
| 5-Year ReturnCumulative with dividends | -20.6% | +49.9% |
| 10-Year ReturnCumulative with dividends | -20.6% | +150.1% |
| CAGR (3Y)Annualised 3-year return | -7.4% | +9.2% |
Risk & Volatility
PG is the less volatile stock with a 0.12 beta — it tends to amplify market swings less than KVUE's 0.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PG currently trades 92.9% from its 52-week high vs KVUE's 76.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | KVUEKenvue Inc. | PGThe Procter & Gam… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.22x | 0.12x |
| 52-Week HighHighest price in past year | $25.17 | $179.99 |
| 52-Week LowLowest price in past year | $14.02 | $137.62 |
| % of 52W HighCurrent price vs 52-week peak | +76.0% | +92.9% |
| RSI (14)Momentum oscillator 0–100 | 69.2 | 66.3 |
| Avg Volume (50D)Average daily shares traded | 41.1M | 9.4M |
Analyst Outlook
Wall Street rates KVUE as "Hold" and PG as "Buy". Consensus price targets imply 0.3% upside for PG (target: $168) vs -2.9% for KVUE (target: $19). For income investors, KVUE offers the higher dividend yield at 4.22% vs PG's 2.41%.
| Metric | KVUEKenvue Inc. | PGThe Procter & Gam… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $18.57 | $167.67 |
| # AnalystsCovering analysts | 14 | 51 |
| Dividend YieldAnnual dividend ÷ price | +4.2% | +2.4% |
| Dividend StreakConsecutive years of raises | 0 | 36 |
| Dividend / ShareAnnual DPS | $0.81 | $4.02 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +1.7% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | May 23 | Feb 26 | Change |
|---|---|---|---|
| Kenvue Inc. (KVUE) | 100 | 64.61 | -35.4% |
| The Procter & Gambl… (PG) | 100 | 106.41 | +6.4% |
The Procter & Gambl… (PG) returned +50% over 5 years vs Kenvue Inc. (KVUE)'s -21%. A $10,000 investment in PG 5 years ago would be worth $14,991 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Kenvue Inc. (KVUE) | $14.5B | $15.5B | +6.8% |
| The Procter & Gambl… (PG) | $65.3B | $84.3B | +29.1% |
The Procter & Gamble Company's revenue grew from $65.3B (2016) to $84.3B (2025) — a 2.9% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Kenvue Inc. (KVUE) | -6.1% | 6.7% | +209.7% |
| The Procter & Gambl… (PG) | 16.1% | 19.0% | +17.8% |
The Procter & Gamble Company's net margin went from 16% (2016) to 19% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| The Procter & Gambl… (PG) | 16.4 | 22 | +34.1% |
The Procter & Gamble Company has traded in a 16x–87x P/E range over 9 years; current trailing P/E is ~26x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Kenvue Inc. (KVUE) | -0.47 | 0.54 | +214.9% |
| The Procter & Gambl… (PG) | 3.69 | 6.51 | +76.4% |
The Procter & Gamble Company's EPS grew from $3.69 (2016) to $6.51 (2025) — a 7% CAGR.
Chart 6Free Cash Flow — 5 Years
Kenvue Inc. generated $1B FCF in 2024 (+3323% vs 2021). The Procter & Gamble Company generated $14B FCF in 2025 (-10% vs 2021).
KVUE vs PG: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is KVUE or PG a better buy right now?
The Procter & Gamble Company (PG) offers the better valuation at 25.7x trailing P/E (24.0x forward), making it the more compelling value choice. Analysts rate The Procter & Gamble Company (PG) a "Buy" — based on 51 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — KVUE or PG?
On trailing P/E, The Procter & Gamble Company (PG) is the cheapest at 25.7x versus Kenvue Inc. at 35.4x. On forward P/E, Kenvue Inc. is actually cheaper at 17.0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — KVUE or PG?
Over the past 5 years, The Procter & Gamble Company (PG) delivered a total return of +49.9%, compared to -20.6% for Kenvue Inc. (KVUE). A $10,000 investment in PG five years ago would be worth approximately $15K today (assuming dividends reinvested). Over 10 years, the gap is even starker: PG returned +150.1% versus KVUE's -20.6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — KVUE or PG?
By beta (market sensitivity over 5 years), The Procter & Gamble Company (PG) is the lower-risk stock at 0.12β versus Kenvue Inc.'s 0.22β — meaning KVUE is approximately 85% more volatile than PG relative to the S&P 500. On balance sheet safety, The Procter & Gamble Company (PG) carries a lower debt/equity ratio of 68% versus 90% for Kenvue Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — KVUE or PG?
The Procter & Gamble Company (PG) is the more profitable company, earning 19.0% net margin versus 6.7% for Kenvue Inc. — meaning it keeps 19.0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24.3% versus 11.9% for KVUE. At the gross margin level — before operating expenses — KVUE leads at 58.0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is KVUE or PG more undervalued right now?
On forward earnings alone, Kenvue Inc. (KVUE) trades at 17.0x forward P/E versus 24.0x for The Procter & Gamble Company — 7.0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PG: 0.3% to $167.67.
07Which pays a better dividend — KVUE or PG?
All stocks in this comparison pay dividends. Kenvue Inc. (KVUE) offers the highest yield at 4.2%, versus 2.4% for The Procter & Gamble Company (PG).
08Is KVUE or PG better for a retirement portfolio?
For long-horizon retirement investors, The Procter & Gamble Company (PG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.12), 2.4% yield, +150.1% 10Y return). Both have compounded well over 10 years (PG: +150.1%, KVUE: -20.6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between KVUE and PG?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: KVUE is a mid-cap income-oriented stock; PG is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.